Skip to content

Outcomes of a Novel Technique of Mini- Incision and Self-Express (MISE) for Breast Abscess

A Comparison of the Outcomes of a Novel Technique of Mini- Incision and Self-Express (MISE) for Breast Abscess With the Conventional Techniques: A Retrospective Comparative Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05762016
Enrollment
30
Registered
2023-03-09
Start date
2018-01-01
Completion date
2024-10-31
Last updated
2023-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Infection

Brief summary

Conventional techniques for treatment of breast abscess, such as incision and drainage/percutaneous drainage, have disadvantages. Bedside Mini-Incision and Self-Express (MISE) is a novel technique for breast abscess. The outcomes of MISE were compared to the conventional techniques.

Detailed description

outcomes such as recovery time, duration of antibiotics use etc will be compared between the various groups of intervention.

Interventions

PROCEDUREBedside Mini-Incision and Self-Express (MISE)

To perform bedside mini incision and encourage patients to self express the pus following the intervention

Sponsors

KK Women's and Children's Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years

Inclusion criteria

* Patients with a pathologically confirmed breast abscess and * presenting at KK Women's and Children's Hospital, Singapore

Exclusion criteria

Patients with: * mastitis * granulomatous mastitis * breast fillers with infection * ruptured abscess prior to intervention * other interventions or bilateral breast infection

Design outcomes

Primary

MeasureTime frameDescription
recovery timefrom diagnosis to date of documented recovery defined as resolution of abscess, assessed up to 2 yearsrecovery time for the abscess to resolve

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026